SVB Leerink Maintains Market Perform on bluebird bio, Raises Price Target to $9

Benzinga · 01/06/2023 17:11
SVB Leerink analyst Mani Foroohar maintains bluebird bio (NASDAQ:BLUE) with a Market Perform and raises the price target from $8 to $9.